Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Authors
Keywords
-
Journal
SCIENCE
Volume 355, Issue 6332, Pages 1423-1427
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-03-10
DOI
10.1126/science.aaf0683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- CD28 Costimulation: From Mechanism to Therapy
- (2016) Jonathan H. Esensten et al. IMMUNITY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
- (2016) B. Homet Moreno et al. Cancer Immunology Research
- Abstract 1317: Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
- (2015) Alice O. Kamphorst et al. CANCER RESEARCH
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- An obligate cell-intrinsic function for CD28 in Tregs
- (2013) Ruan Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
- (2011) A. M. Paterson et al. JOURNAL OF IMMUNOLOGY
- Limiting the Amount and Duration of Antigen Exposure during Priming Increases Memory T Cell Requirement for Costimulation during Recall
- (2011) T. L. Floyd et al. JOURNAL OF IMMUNOLOGY
- Multiple Layers of CD80/86-Dependent Costimulatory Activity Regulate Primary, Memory, and Secondary Lymphocytic Choriomeningitis Virus-Specific T Cell Immunity
- (2011) J. Eberlein et al. JOURNAL OF VIROLOGY
- PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice
- (2010) Scott N. Mueller et al. JOURNAL OF CLINICAL INVESTIGATION
- MART-1–Specific Melanoma Tumor-Infiltrating Lymphocytes Maintaining CD28 Expression Have Improved Survival and Expansion Capability Following Antigenic Restimulation In Vitro
- (2009) Yufeng Li et al. JOURNAL OF IMMUNOLOGY
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
- (2008) Joseph D. Miller et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started